SCHEMBL8621609

SCHEMBL8621609

Cc1nc(CCC2CCN(C(=O)OCc3ccccc3)CC2)sc1C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.51
CYP2C19 P33261 1/20 0.51
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
GRIN2B Q13224 13/20 0.49
CYP2D6 P10635 4/20 0.48
CYP2C9 P11712 4/20 0.48
FAAH O00519 1/20 0.48
HTT P42858 1/20 0.47
CYP3A4 P08684 3/20 0.46
CHRM4 P08173 1/20 0.44
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8554226 0.92 SMN1; SMN2 (0.47) SMN1; SMN2CYP2C19NPC1RAB9AGRIN2B
SCHEMBL8549687 0.85 HTT (0.47) SMN1; SMN2CYP2C19NPC1RAB9AGRIN2B
SCHEMBL8552715 0.84 LMNA (0.47) SMN1; SMN2CYP2C19NPC1RAB9AGRIN2B
SCHEMBL8552717 0.84 LMNA (0.47) SMN1; SMN2CYP2C19NPC1RAB9AGRIN2B
SCHEMBL8594128 0.82 SMN1; SMN2 (0.55) SMN1; SMN2CYP2C19NPC1RAB9AGRIN2B
SCHEMBL8621606 0.79 SMN1; SMN2 (0.52) SMN1; SMN2CYP2C19NPC1RAB9AGRIN2B
SCHEMBL8626988 0.79 GRIN2B (0.52) SMN1; SMN2CYP2C19NPC1RAB9AGRIN2B
SCHEMBL9377530 0.78 BCHE (0.47) SMN1; SMN2CYP2C19NPC1RAB9AGRIN2B
SCHEMBL15140566 0.77 SMN1; SMN2 (0.72) SMN1; SMN2CYP2C19NPC1RAB9AGRIN2B
SCHEMBL13519706 0.76 SMN1; SMN2 (0.67) SMN1; SMN2CYP2C19NPC1RAB9AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5817677-A ANTITHROMBOSIS AGENTS DR. KARL THOMAE GMBH (DE) 1998-10-06 US disclosed